Viewing Study NCT04809766


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-01-25 @ 1:57 AM
Study NCT ID: NCT04809766
Status: TERMINATED
Last Update Posted: 2025-04-20
First Post: 2021-03-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Mesothelin-Specific T-Cells (FH-TCR-Tᴍsʟɴ) for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Sponsor: Fred Hutchinson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: RG1007292
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View